BIOMAT Database Logo BIOMAT Database Logo

Different binding epitopes on the NK1 receptor for substance P and non-peptide antagonist. 1993

U Gether, and T E Johansen, and R M Snider, and J A Lowe, and S Nakanishi, and T W Schwartz
University Department of Clinical Biochemistry, Rigshospitalet, Copenhagen, Denmark.

Non-peptide ligands for peptide receptors have been discovered in several systems through file screening programs, but the mechanism of action for these candidate drugs is obscure as they do not chemically resemble the native peptides. The compound CP 96345 is a high-affinity, non-peptide antagonist of the substance P (NK1) receptor, which is important in pain perception and neurogenic inflammation. Here we identify epitopes on the NK1 receptor responsible for the specific binding of CP 96345 by systematic exchange of corresponding segments between the NK1 receptor and the homologous NK3 (neurokinin B) receptor, which does not bind the non-peptide ligand. Non-conserved residues, in two epitopes around the top of transmembrane segment V and in one epitope at the top of transmembrane segment VI, are essential for the specific action of CP 96345 on the NK1 receptor, but are surprisingly not important for the binding of the natural peptide ligand, substance P. Susceptibility to the non-peptide antagonists can be conveyed to the previously unresponsive NK3 receptor by mutational transfer of this discontinuous epitope from the NK1 receptor.

UI MeSH Term Description Entries
D008969 Molecular Sequence Data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories. Sequence Data, Molecular,Molecular Sequencing Data,Data, Molecular Sequence,Data, Molecular Sequencing,Sequencing Data, Molecular
D011994 Recombinant Proteins Proteins prepared by recombinant DNA technology. Biosynthetic Protein,Biosynthetic Proteins,DNA Recombinant Proteins,Recombinant Protein,Proteins, Biosynthetic,Proteins, Recombinant DNA,DNA Proteins, Recombinant,Protein, Biosynthetic,Protein, Recombinant,Proteins, DNA Recombinant,Proteins, Recombinant,Recombinant DNA Proteins,Recombinant Proteins, DNA
D000595 Amino Acid Sequence The order of amino acids as they occur in a polypeptide chain. This is referred to as the primary structure of proteins. It is of fundamental importance in determining PROTEIN CONFORMATION. Protein Structure, Primary,Amino Acid Sequences,Sequence, Amino Acid,Sequences, Amino Acid,Primary Protein Structure,Primary Protein Structures,Protein Structures, Primary,Structure, Primary Protein,Structures, Primary Protein
D000939 Epitopes Sites on an antigen that interact with specific antibodies. Antigenic Determinant,Antigenic Determinants,Antigenic Specificity,Epitope,Determinant, Antigenic,Determinants, Antigenic,Specificity, Antigenic
D001665 Binding Sites The parts of a macromolecule that directly participate in its specific combination with another molecule. Combining Site,Binding Site,Combining Sites,Site, Binding,Site, Combining,Sites, Binding,Sites, Combining
D001713 Biphenyl Compounds Whitish aromatic crystalline organic compounds made up of two conjoined BENZENE rings. Compounds, Biphenyl
D015320 Tachykinins A family of biologically active peptides sharing a common conserved C-terminal sequence, -Phe-X-Gly-Leu-Met-NH2, where X is either an aromatic or a branched aliphatic amino acid. Members of this family have been found in mammals, amphibians, and mollusks. Tachykinins have diverse pharmacological actions in the central nervous system and the cardiovascular, genitourinary, respiratory, and gastrointestinal systems, as well as in glandular tissues. This diversity of activity is due to the existence of three or more subtypes of tachykinin receptors. Tachykinin
D017981 Receptors, Neurotransmitter Cell surface receptors that bind signalling molecules released by neurons and convert these signals into intracellular changes influencing the behavior of cells. Neurotransmitter is used here in its most general sense, including not only messengers that act to regulate ion channels, but also those which act on second messenger systems and those which may act at a distance from their release sites. Included are receptors for neuromodulators, neuroregulators, neuromediators, and neurohumors, whether or not located at synapses. Neurohumor Receptors,Neuromediator Receptors,Neuromodulator Receptors,Neuroregulator Receptors,Receptors, Neurohumor,Receptors, Synaptic,Synaptic Receptor,Synaptic Receptors,Neuromediator Receptor,Neuromodulator Receptor,Neuroregulator Receptor,Neurotransmitter Receptor,Receptors, Neuromediators,Receptors, Neuromodulators,Receptors, Neuroregulators,Receptors, Neurotransmitters,Neuromediators Receptors,Neuromodulators Receptors,Neuroregulators Receptors,Neurotransmitter Receptors,Neurotransmitters Receptors,Receptor, Neuromediator,Receptor, Neuromodulator,Receptor, Neuroregulator,Receptor, Neurotransmitter,Receptor, Synaptic,Receptors, Neuromediator,Receptors, Neuromodulator,Receptors, Neuroregulator
D018041 Receptors, Neurokinin-2 A class of cell surface receptors for tachykinins that prefers neurokinin A; (NKA, substance K, neurokinin alpha, neuromedin L), neuropeptide K; (NPK); or neuropeptide gamma over other tachykinins. Neurokinin-2 (NK-2) receptors have been cloned and are similar to other G-protein coupled receptors. NK-2 Receptors,Neurokinin A Receptors,Neurokinin-2 Receptors,Receptors, NK-2,Receptors, Substance K,SP-K Receptors,Substance K Receptors,NK-2 Receptor,NK-2 Receptor Site,Neurokinin-2 Receptor,SP-K Receptor,Substance K Receptor,NK 2 Receptor,NK 2 Receptor Site,NK 2 Receptors,Neurokinin 2 Receptor,Neurokinin 2 Receptors,Receptor Site, NK-2,Receptor, NK-2,Receptor, Neurokinin-2,Receptor, SP-K,Receptor, Substance K,Receptors, NK 2,Receptors, Neurokinin 2,Receptors, Neurokinin A,Receptors, SP-K,SP K Receptor,SP K Receptors

Related Publications

U Gether, and T E Johansen, and R M Snider, and J A Lowe, and S Nakanishi, and T W Schwartz
A potent nonpeptide antagonist of the substance P (NK1) receptor.
January 1991, Science (New York, N.Y.),
U Gether, and T E Johansen, and R M Snider, and J A Lowe, and S Nakanishi, and T W Schwartz
Cyclosporin A is a substance P (tachykinin NK1) receptor antagonist.
May 1995, European journal of pharmacology,
U Gether, and T E Johansen, and R M Snider, and J A Lowe, and S Nakanishi, and T W Schwartz
Activity and distribution of binding sites in brain of a nonpeptide substance P (NK1) receptor antagonist.
January 1991, Science (New York, N.Y.),
U Gether, and T E Johansen, and R M Snider, and J A Lowe, and S Nakanishi, and T W Schwartz
Characterization of non-peptide antagonist and peptide agonist binding sites of the NK1 receptor with fluorescent ligands.
August 1997, The Journal of biological chemistry,
U Gether, and T E Johansen, and R M Snider, and J A Lowe, and S Nakanishi, and T W Schwartz
Antiinflammatory and analgesic activity of a non-peptide substance P receptor antagonist.
July 1992, European journal of pharmacology,
U Gether, and T E Johansen, and R M Snider, and J A Lowe, and S Nakanishi, and T W Schwartz
FR 113680: a novel tripeptide substance P antagonist with NK1 receptor selectivity.
May 1992, British journal of pharmacology,
U Gether, and T E Johansen, and R M Snider, and J A Lowe, and S Nakanishi, and T W Schwartz
The substance P (NK1) receptor antagonist L-760735 inhibits fear conditioning in gerbils.
March 2003, Neuropharmacology,
U Gether, and T E Johansen, and R M Snider, and J A Lowe, and S Nakanishi, and T W Schwartz
Neurobiology of substance P and the NK1 receptor.
January 2002, The Journal of clinical psychiatry,
U Gether, and T E Johansen, and R M Snider, and J A Lowe, and S Nakanishi, and T W Schwartz
N- and C-terminal substance P fragments: differential effects on striatal [3H]substance P binding and NK1 receptor internalization.
July 1999, Neuroreport,
U Gether, and T E Johansen, and R M Snider, and J A Lowe, and S Nakanishi, and T W Schwartz
Effects of CP-99,994, an NK1-receptor antagonist, on the inward current produced by substance P.
January 1995, The Kurume medical journal,
Copied contents to your clipboard!